Anika Reports Second Quarter 2025 Financial Results

  • Regenerative Solutions revenue up 41% with Integrity \u2122 Implant System ahead of expectations and continued strong Hyalofast\u00ae growth; Integrity surpasses full year 2024 performance and is on pace to more than double in 2025